Olmesartan Medoxomil/Azelnidipine

奥美沙坦酯/阿折地平

Report date: 2023/04/25 11:29:33

Base Information

Drug NameOlmesartan Medoxomil/Azelnidipine
Drug Alias NameOlmesartan Medoxomil•Azelnidipine奥美沙坦酯-阿折地平复方Olmesartan Medoxomil-Azelnidipine mixt阿折地平/奥美沙坦酯Olmesartan Medoxomil and Azelnidipine +[13] 
ClassificationSmall molecules
Mechanisms of ActionVoltage-gated L-type calcium channel blockersAngiotensin II Receptor Type 1 antagonists
TargetsAngiotensin II Receptor Type 1Voltage-gated L-type calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2010/01/20
Country/TerritoryJapan
CombinationsYes Olmesartan MedoxomilAzelnidipine
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesDaiichi Sankyo Co Ltd
Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09D
Related LinksKEGG